| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| P911515 | 85532-75-8 | PK-11195, 98% PK-11195, 98% |
C21H21ClN2O | |
| P910679 | 874146-69-7 | PK11007, 98% PK11007, 98% |
C15H11ClFN6O3S2 | |
| P913255 | 99534-03-9 | PKA Inhibitor (5-24), 98% PKA Inhibitor (5-24) (PKI (5-24), 98% |
C94H148N32O31 | |
| P934101 | 172308-76-8 | PKC β pseudosubstrate, ≥98% PKC β pseudosubstrate, ≥98% |
C177H294N62O38S3 | |
| P912696 | 799764-07-1 | PKCzeta Pseudosubstrate Inhibitor, 98% PKCzeta Pseudosubstrate Inhibitor, 98% |
C76H128N30O16 | |
| P911833 | 182683-50-7 | PKCε Inhibitor Peptide, 98% PKCε Inhibitor Peptide, 98% |
C37H65N9O13 | |
| P912768 | 82801-73-8 | PKG Inhibitor, 98% PKG Inhibitor, 98% |
C38H74N18O10 | |
| P933928 | 201422-03-9 | PKI 14-22 amide,myristoylated, ≥98% PKI 14-22 amide,myristoylated, ≥98% |
C53H100N20O12 | |
| P911439 | 608512-97-6 | PKR-IN-C16, 98% PKR-IN-C16, 98% |
C13H8N4OS | |
| P795760 | 608512-97-6 | PKR-IN-C16, 10mM in DMSO PKR-IN-C16, 10mM in DMSO |
C13H8N4OS | |
| P996122 | 445493-23-2 | Pladienolide B, ≥98% Pladienolide B, ≥98% |
C30H48O8 | |
| P912892 | 869898-86-2 | Platencin, 98% Platencin, 98% |
C24H27NO6 | |
| P793077 | 1303420-67-8 | PLX5622, 10mM in DMSO PLX 5622, PLX-5622, 10mM in DMSO |
C21H19F2N5O | |
| P910295 | 1303420-67-8 | PLX5622, 98% PLX 5622,PLX-5622, 98% |
C21H19F2N5O | |
| P933228 | 113852-41-8 | PMEDAP, ≥98% PMEDAP, ≥98% |
C8H13N6O4P | |
| P936947 | 21886-12-4 | PNU 112455A盐酸盐, 98% PNU112455A hydrochloride, 98% |
C10H12ClN5O2S | |
| P933724 | 301692-76-2 | Polmacoxib, ≥98% Polmacoxib, ≥98% |
C18H16FNO4S | |
| P936534 | 1949843-39-3 | Poly(oxy-1,2-ethanediyl), α-[2-[(2-carboxyethyl)amino]ethyl]-ω-methoxy-, ≥95% m-PEG12-NH-C2-acid, ≥95% |
C28H57NO14 | |
| P912706 | 80469-10-9 | Polymyxin B1 Isoleucine, 98% Polymyxin B1 Isoleucine, 98% |
C56H98N16O13 | |
| P960277 | 19171-19-8 | Pomalidomide, ≥99.5% Pomalidomide, ≥99.5% |
C13H11N3O4 |